Results 81 to 90 of about 52,364 (182)

Effect of olopatadine hydrochloride, a novel antiallergic agent, on the QT interval in dogs.

Folia Pharmacologica Japonica, 2001
Olopatadine hydrochloride (olopatadine), a novel antiallergic agent, is effective in the treatment of allergic rhinitis, chronic urticaria, eczema and dermatitis. It has been reported that terfenadine and astemizole cause side effects on the circulatory system such as QT prolongation followed by serious ventricular arrhythmias (torsades de pointes). To
IWAMOTO, Ken-ichiro, IKEDA, Jun-ichi, NITO, Masaaki, KOSAKA, Nobuo, ICHIKAWA, Shunji, KOBAYASHI, Hiroyuki, OHMORI, Kenji   +6 more
openaire   +3 more sources

Development and in vitro/in vivo evaluation of thermo-sensitive in situ gelling systems for ocular allergy

Brazilian Journal of Pharmaceutical Sciences
Ocular allergy is one of the most common disorders of the eye surface. Following diagnosis this condition is typically treated with preparations containing antihistamines.
Umay Merve Güven, Murat Sami Berkman, Behiye Şenel, Yasemin Yazan   +3 more
doaj   +1 more source

Zero order derivative spectroscopic estimation of olopatadine hydrochloride from Eye Drops

, 2016
New simple, precise, accurate and cost effective UV spectrophotometric method was developed for the estimation of olopatadine hydrochloride from its ophthalmic dosage form by zero order (Dº) derivative spectroscopic method.
Furquan Khan, Sarfaraz Khan, Mirza Shahid Baig, Darakhshan Afreen Shaikh, Zahid Zaheer   +4 more
core  

Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays

Pharmaceutics
The deposition, residence time, and dissolution profile of nasal suspensions containing corticosteroids play a key role in their in vivo efficacy after administration.
Virginia Patterlini, Fabiola Guareschi, Davide D’Angelo, Simone Baldini, Suada Meto, Dalia Mostafa Kamal, Paolo Fabrizzi, Francesca Buttini, Ralph Mösges, Fabio Sonvico   +9 more
doaj   +1 more source

Formulation of olopatadine hydrochloride viscous eye drops – physicochemical, biopharmaceutical and efficacy assessment using in vitro and in vivo approaches

, 2021
The aim of this work was the formulation and the comprehensive evaluation of the viscous eye drops using vehicles containing medium chain chitosan (0.5% w/v), hydroxypropyl guar gum (0.25% w/v) and their com-bination as carriers for olopatadine (0.1% w/v)
Račić, Andjelka, Dobričić, Vladimir, Krajišnik, Danina, Milić, Jela, Lovrić, Jasmina, Stepanović-Petrović, Radica, Micov, Ana, Vuković, Milja, Čalija, Bojan, Jurišić Dukovski, Bisera   +9 more
core   +1 more source

Evaluation of olopatadine 0.2% in the complete prevention of ocular itching in the conjunctival allergen challenge model

Clinical Optometry, 2011
Alan G Kabat1, David B Granet2, Dina Amin3, Maria J Tort3, Michael S Blaiss41Nova Southeastern University, Fort Lauderdale, FL, USA; 2Shiley Eye Center, University of California San Diego, La Jolla, CA, USA; 3Alcon Research Ltd, Fort Worth, TX, USA ...
Kabat AG, Granet DB, Amin D, Tort MJ, Blaiss MS   +4 more
doaj  

Evaluation of Olopatadine Hydrochloride Nasal Spray, 0.6%, Used in Combination with an Intranasal Corticosteroid in Seasonal Allergic Rhinitis

Allergy & Rhinology, 2010
The combination of intranasal antihistamines and intranasal corticosteroids results in superior relief of seasonal allergic rhinitis (SAR) symptoms compared with monotherapy.
Craig F. LaForce M.D., Warner Carr M.D., Stephen A. Tilles M.D., Bradley E. Chipps M.D., William Storms M.D., Eli O. Meltzer M.D., Michael Edwards Ph.D.   +6 more
doaj   +1 more source

Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study

Patient Preference and Adherence, 2023
Simon Fifer,1 Lili Toh,1 Hanmant Barkate,2 Vineet Aggarwal,2 Dhammraj Borade,2 Roger Hereward Gordonsmith,3 Wen Wu,3 Claire Morgan,4 Katherine Young4 1Community and Patient Preference Research (CaPPRe) Pty Ltd, Sydney, New South Wales, Australia; 2Global
Fifer S, Toh L, Barkate H, Aggarwal V, Borade D, Gordonsmith RH, Wu W, Morgan C, Young K   +8 more
doaj  

Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study. [PDF]

Patient Prefer Adherence, 2023
Fifer S, Toh L, Barkate H, Aggarwal V, Borade D, Gordonsmith RH, Wu W, Morgan C, Young K.   +8 more
europepmc   +1 more source

Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%

Clinical Ophthalmology, 2011
Jack V Greiner1,2, Kimberly Edwards-Swanson3, Avner Ingerman41Schepens Eye Research Institute, Boston, MA; 2Department of Ophthalmology, Harvard Medical School, Boston, MA; 3Johnson & Johnson Consumer and Personal Products Worldwide, Skillman, NJ;
Jack V Greiner, Kimberly Edwards-Swanson, Avner Ingerman   +2 more
doaj